Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02469597 · ClinicalTrials.gov registry record · Phase 2
Single Dose of Furosemide to Improve Respiratory Distress in Moderate to Severe Bronchiolitis
A Phase 2 study, sponsored by Northwell Health.
- Completed
- Registry status
- Phase 2
- Development phase
- 46
- Enrollment target
NCT02469597 is a Phase 2 study that has completed, run by Northwell Health. The registered enrollment target is 46 participants.
The verdict
NCT02469597, a Phase 2 study, has completed, sponsored by Northwell Health.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 46 participants
- Enrollment target
Study Summary
The purpose of this study is to assess if administration of an early single dose of a diuretic (furosemide) to children with moderate to severe bronchiolitis can reduce extravascular lung water in an effort to reduce respiratory rate, retractions, intubations, and length of stay.
Interventions
- DRUG Placebo
- DRUG Furosemide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2013-10 |
| Est. Completion | 2016-04 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02469597
The ClinicalTrials.gov registry entry for NCT02469597 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 46 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwell Health, which has 370 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT02469597 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02469597 about?
NCT02469597 is a clinical study titled "Single Dose of Furosemide to Improve Respiratory Distress in Moderate to Severe Bronchiolitis". The purpose of this study is to assess if administration of an early single dose of a diuretic (furosemide) to children with moderate to severe bronchiolitis can reduce extravascular lung water in an effort to reduce respiratory rate, retractions, intubations, and length of stay.
What is the current status of trial NCT02469597?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 46 participants. The study started on 2013-10. Estimated completion is 2016-04.
What interventions are being tested in trial NCT02469597?
The interventions under investigation include: Placebo (DRUG), Furosemide (DRUG).
Who is sponsoring clinical trial NCT02469597?
This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.